ISRG Intuitive Surgical NASDAQ Pre-Mkt $478.60 Feb 2026: daVinci5 adoption key

We see ISRG stock trading pre-market at USD 478.60, down after a short-term pullback. Intuitive Surgical, Inc. (ISRG) reported a strong quarter with EPS 7.87 and revenue beats, yet the stock is reacting to valuation and insider sales. We focus on procedure growth, daVinci 5 adoption, and how those trends link to short- and medium-term price action in the United States (NASDAQ).

ISRG stock: Pre-market price action and volume

ISRG stock opened the session near USD 496.12 and is showing last trade USD 478.60, a intraday swing tied to profit-taking and sector rotation. Volume is elevated at 2,962,992.00 versus an average of 1,896,655.00, signaling heavier-than-normal selling interest in early trading.

ISRG stock: Recent earnings, procedures and guidance

Intuitive Surgical reported quarterly revenue of USD 2.87 billion and EPS of 7.87, beating estimates and showing procedure growth led by daVinci 5 and SP platform gains. Management guided 13.00-15.00% global da Vinci procedure growth in 2026, which underpins recurring instrument and services revenue and supports medium-term adoption trends.

ISRG stock: Valuation and key financial ratios

Valuation remains premium with a trailing P/E around 60.81 and price-to-sales near 16.90. Cash per share is 16.72 and book value per share is 50.55, while return on equity is about 16.39%, showing profitability despite the high multiple.

ISRG stock: Technical setup and trading signals

Technicals show RSI 65.69 and a 50-day average of 545.70 versus the current price 478.60, indicating a pullback toward support. Short-term indicators show moderate momentum and a relative volume spike; traders will watch the 50-day and 200-day moving averages at 545.70 and 516.29 respectively.

ISRG stock: Risks, competitive landscape and AI-driven opportunities

Risks include margin pressure from tariffs, pricing competition in China, and recent insider selling that may weigh sentiment. Opportunities include expanded procedure categories, ASC penetration, and data-driven optimizations that fit the AI stocks strategy and can lift utilization over time. See coverage and recent reporting for context MarketBeat news on ISRG and the deeper story at Nasdaq analysis of ISRG.

Meyka AI rating and model forecast for ISRG stock

Meyka AI rates ISRG with a score out of 100: 79.63 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12‑month target of USD 604.32, offering an implied upside of 26.28% versus the current price USD 478.60. Forecasts are model-based projections and not guarantees.

Final Thoughts

Key takeaways on ISRG stock: the company continues to show strong procedure growth and product-cycle momentum driven by daVinci 5 and SP platform adoption, but the share price is under pressure from a premium valuation and short-term sentiment factors. Financials show solid cash per share USD 16.72, EPS 7.87, and a high P/E 60.81 that leaves little margin for execution misses. Meyka AI’s forecast model projects a 12‑month level of USD 604.32, implying 26.28% upside from USD 478.60, while a nearer-term monthly projection sits near USD 424.33, reflecting potential volatility. We view ISRG as a growth name with execution risk; institutional interest and recurring revenue give it resiliency, but investors should weigh premium multiples and region-specific headwinds. For ongoing coverage, see our ISRG page at Meyka stock page.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.